Search results
Showing 6046 to 6060 of 8216 results
Seven digital platforms supporting at home cardiac rehab given conditional recommendations
People with heart disease will be able to do their recovery sessions from home rather than travelling for rehabilitation appointments after our independent committee conditionally recommended 7 digital platforms for use in the NHS.
The government has today (1 December 2025) announced that it will increase the thresholds NICE uses in evaluations of new medicines to decide which are cost-effective for use in the NHS.
NICE's prioritisation process explained – what healthtech developers need to know
Understand why we're prioritising key topic areas for evaluation and what it means for innovators
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
The adoption and implementation team provides support to the system to enable the effective use of NICE guidance.
Process guide for adoption support resources for health technologies (PMG23)
This process and methods guide has been withdrawn.
This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.
This guidance has been updated and replaced by NICE guideline NG130.
Myocardial infarction with ST-segment elevation: acute management (CG167)
This guideline has been updated and replaced by NICE guideline NG185.
Acute kidney injury: prevention, detection and management (CG169)
This guidance has been updated and replaced by NICE guideline NG148.
Dyspepsia: Management of dyspepsia in adults in primary care (CG17)
This guidance has been updated and replaced by NICE guideline CG184.
This guideline has been updated and replaced by NICE guideline NG123.
This guideline has been updated and replaced by NICE guideline NG185.
This guideline has been updated and replaced by the NICE guideline on intrapartum care (NG235).
This guidance has been updated and replaced by NICE guideline CG82.